Suture Triangular Needle 1 Braided Biocryl

The Biocryl 1 Braided Triangular Needle Suture represents an innovative solution for surgical suturing needs, offering a high quality product specifically designed to ensure resistance, ease of handling and reliability during medical procedures. It is an absorbable synthetic suture, braided and supplied with a cutting needle with a triangular section, ideal for dealing with tissues that require high precision and effective penetration. Thanks to its characteristics, Biocryl thread stands out for its softness and flexibility which facilitates knotting, reducing the risk of trauma during application. Its woven structure ensures high knot strength and stability of the wound edges, while the polymer composition ensures predictable and gradual absorption, minimizing the inflammatory reaction of the tissues and promoting optimal healing. This type of suture is particularly suitable for procedures where medium wound support times are required, thanks to the progressive release of the mechanical properties that accompany the natural healing processes of the tissues.

The triangular needle associated with the suture allows precise penetration even into the most resistant tissues, reducing the risk of tears and facilitating passage through different anatomical layers. The sterile packaging helps reduce the risk of post-operative infections and guarantees maximum safety for the patient and the healthcare worker. Every detail of this suture has been designed to offer constant performance, from ease of insertion to comfort in manipulation, up to the flexibility essential for the most modern surgical techniques.

Therapeutic Indications

The Biocryl 1 Braided Triangular Needle Suture is indicated for the closure and adaptation of soft tissues in various areas of general, gynecological, urological, orthopedic and plastic surgery. Its woven structure and absorbable material make it particularly suitable for all those cases where temporary support for wound healing is necessary, with the certainty that the material will be progressively reabsorbed by the body without the need for manual removal. It is widely used in the suturing of visceral tissues and subcutaneous fascia, as well as in the closure of surgical incisions and in tissue reconstructions where it is desired to minimize residual scarring. The triangular needle facilitates passage through fibrous or medium-resistant tissues, providing optimal penetration and allowing precise placement of the sutures, which is essential to guarantee good wound coaptation and complete integrity of the fascia or skin.

The Biocryl suture is also ideal for pediatric procedures and in patients at risk of adverse reactions to traditional materials, as the biocompatible composition has been designed to reduce irritation and granuloma phenomena. It is always recommended to evaluate the specific clinical situation and the type of tissues involved to ensure the best possible result: the versatility of the Biocryl 1 Braided Triangular Needle Suture allows the surgeon to safely manage both routine procedures and complex cases where control, reliability and delicacy in the adaptation of the tissue flaps is required. It is therefore strongly recommended for operations where a balance between tensile strength and ease of intraoperative manipulation is necessary.

Composition

Active ingredient: The suture is made with a synthetic material based on polyglycolic acid copolymer, known for its rapid and regular absorption by the tissues. The thread is braided and has a slightly wrinkled surface, ideal for providing an effective hold on the knots and preventing involuntary slippage during the surgical procedure. The color of the suture, generally purple or transparent, allows optimal visibility in the operating field depending on the needs of the operators and the characteristics of the tissue treated.

The needle supplied with the suture is of the triangular (sharp) type, made of high quality stainless steel, resistant to bending and extremely sharp to ensure easy access into the tissues. The additive elements present in the thread are designed to be completely bioassimilable during progressive reabsorption, without leaving residues or causing alterations in tissue physiology. Furthermore, the Biocryl thread is presented in a single sterile package, free of allergenic substances, latex free and certified for use in the operating room in accordance with the highest safety and sterility standards.

Contraindications

The application of the Biocryl 1 Braided Triangular Needle Suture in tissues that require long-lasting support, such as vascular prostheses or tissues that are subjected to strong tension for prolonged periods, is contraindicated. Do not use in patients with proven hypersensitivity or documented allergy to the basic components of the polymer or to the materials of the needle supplied. Use is not recommended in areas where there is a high probability of persistent infection or the formation of abundant exudate, which could accelerate the process of hydrolysis and absorption of the suture, thus compromising the expected tissue support.

Suturing is not recommended in cases where a prolonged presence of the material is necessary, such as in the points of attachment of tendons, ligaments or situations in which the tissue does not have predictable healing within the timeframe of programmed absorption. Furthermore, its use must be carefully evaluated in patients susceptible to marked local reactive phenomena or with a history of granulomas caused by foreign bodies. Use outside the specified indications could compromise the seal and stability of the suture itself.

Safety of the drug for the species

The extensive clinical and preclinical documentation on Biocryl highlights a high safety of use in humans, with minimal local side effects that are easily manageable from a clinical point of view. The entirely synthetic composition ensures a reduced incidence of allergic phenomena compared to natural or non-absorbable threads, while the predictability of the absorption process reduces the risk of premature loss of mechanical resistance. Studies on animal models and in vitro confirm the low tissue reactivity, the stability of the tension function over the programmed time and the absence of release of toxic or pyrogenic molecules during the decay and reabsorption of the material within the tissues.

The triangular needle design reduces penetration trauma, limiting the destruction of surrounding tissues and contributing to optimal coaptation of the surgical wound. In the event of accidental breakage of the thread or difficulty during the recovery of any segments, the risk of complications remains extremely low, thanks to the biocompatibility guaranteed by the composition of Biocryl. The absence of materials of animal origin or substances known to induce systemic sensitization gives further safety in use, even on patients with a complex clinical history.

Precautions

When handling the Biocryl 1 Braided Triangular Needle Suture it is essential to maintain aseptic conditions to avoid accidental contamination of the sterile device. It is advisable to carefully inspect the packaging before use, ensuring that it is intact and that the product is free of visible defects. Use on infected or seriously compromised tissues must be avoided, or carefully evaluated by medical personnel, as absorption may be accelerated and compromise the cohesion of the wounds. It is important to pay attention when tying knots: excessive traction can alter the woven structure, compromising the resistance of the material, therefore it is recommended to follow standardized techniques to guarantee the best clinical performance.

At the end of the surgical procedure, safely eliminate any residual material and dispose of according to hospital procedures for biohazardous waste. Do not reuse the product and do not attempt to resterilize unused sutures. If in doubt about the correctness of intraoperative manipulation or the integrity of the suture, replace the device immediately to avoid complications. Training in the use of the thread and the triangular needle is strongly recommended to guarantee the highest standards of intraoperative and postoperative safety.

Method of administration

The suture is supplied pre-assembled on a triangular needle, ready for use because it is packaged in a sterile environment. After opening the set, handle with appropriate tools to prevent contamination of the sterile work area. The thread must be used following the standard surgical techniques for absorbable braided threads, taking care to pass the needle with a firm but controlled movement, adapting it to the resistance of the tissues to be treated. Once the suture is finished, it is recommended to make at least three knots, checking the tightness and flexibility to ensure the compactness of the closure.

In the presence of particularly friable tissues or in pediatric patients, it may be advantageous to reduce the intensity of traction on the edges, distributing the stitches evenly along the edge of the wound. Once the suture is completed, carefully remove the remaining ends of the thread to avoid local irritation or inflammation. Biocryl sutures generally do not require removal, as they are completely reabsorbed within a few weeks depending on the position and clinical condition of the patient.

Treatment program

The duration of the support provided by the Biocryl 1 Triangular Needle Suture Braided depends on the site of application and the patient's tissue metabolism. Generally, most mechanical resistance is maintained for a few weeks, with a gradual decline during the biological absorption process (hydrolysis). Under normal conditions, the material is completely reabsorbed within approximately 60-90 days, accompanying the correct healing of the tissues without leaving residues.

To maximize effectiveness, it is advisable to regularly monitor healing, especially in regions subjected to significant mechanical stress, and to plan any follow-ups to evaluate the stable seal of the flaps during the early post-operative phases. In the case of complex interventions, it may be necessary to update the surveillance program and evaluate whether to combine other support or medication techniques. In the presence of indicators of inflammation or infection, the observation scheme must be adapted and the device must be replaced immediately in case of anomalies.

Target species

Humans